In addition, studies have shown that, through high-throughput sequencing and bioinformatics analysis, the expression of CDKN2B-AS1 in peripheral blood of IPF patients is significantly reduced compared with that of healthy controls [13]. Here, CDKN2B is linked to idiopathic pulmonary fibrosis.